CVS Health (CVS)
(Delayed Data from NYSE)
$57.81 USD
-1.51 (-2.55%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $57.97 +0.16 (0.28%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.81 USD
-1.51 (-2.55%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $57.97 +0.16 (0.28%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $65.10 in the latest trading session, marking a +0.14% move from the prior day.
Procter & Gamble to Widen Naturals Line With This is L. Buyout
by Zacks Equity Research
Procter & Gamble (PG) is focusing on the fast-growing 'naturals' business line, with the acquisition of a natural ingredient-based women's products company, This is L.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $65.67, marking a -0.36% move from the previous day.
Why the Earnings Surprise Streak Could Continue for CVS Health (CVS)
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $65.54, marking a +0.46% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $66.11, moving +1.83% from the previous trading session.
CVS Health's PBM Pharmacy Platform to Ride on Walmart Deal
by Zacks Equity Research
Per the terms of the deal between CVS Health (CVS) and Walmart, the latter will continue to take part in the CVS Caremark PBM commercial and Managed Medicaid retail pharmacy networks.
Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health
5 Stocks in Focus After Recent Broker Rating Upgrades
by Zacks Equity Research
The guidance to design a winning portfolio comes from brokers given their thorough understanding of the stock market.
Company News For Jan 16, 2019
by Zacks Equity Research
Companies in the news are: DAL, CVS, WMT, WFC and UAL
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
by Urmimala Biswas
While Amazon is figuring out ways to expand in the multibillion dollar pharmacy industry, Walgreens and other industry players are ready to counter competition.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $65.34, marking a -0.71% move from the previous day.
CVS Health Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
CVS Health Corporation (CVS) has been struggling lately, but the selling pressure may be coming to an end soon.
Zacks Value Trader Highlights: American Airlines, United Continental, Discovery, CVS and Dell Technologies
by Zacks Equity Research
Zacks Value Trader Highlights: American Airlines, United Continental, Discovery, CVS and Dell Technologies
5 Dirt Cheap Big Cap Stocks to Buy Now
by Tracey Ryniec
With the 2018 sell off, some big cap stocks are now trading with P/Es under 10.
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $68.53 in the latest trading session, marking a -0.12% move from the prior day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $68.53 in the latest trading session, marking a -0.12% move from the prior day.
Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?
6 Promising Price-to-Book Value Stocks to Buy Now
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Here's Why You Should Add CVS Health to Your Portfolio Now
by Zacks Equity Research
CVS Health (CVS) is optimistic about synergies from Aetna deal which will help create a robust platform to serve individuals better.